MedPath

Cohort study of immune-checkpoint-inhibitor antibody treatment in non-small-cell lung cancer

Not Applicable
Recruiting
Conditions
non-small-cell lung cancer
Registration Number
JPRN-UMIN000020719
Lead Sponsor
Saitama Medical University International Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Having psychological disorder 2) In addition, the primary doctor judging inappropriate for entry

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
analysis of peripheral blood mononuclear cell(PBMC)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath